Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
20.46
-1.14 (-5.28%)
At close: Sep 23, 2026, 4:00 PM EDT
20.46
0.00 (0.00%)
After-hours: Sep 23, 2026, 4:20 PM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.27 billion as of September 23, 2026. Its market cap has increased by 75.44% in one year.
Market Cap
3.27B
Enterprise Value
2.37B
1-Year Change
75.44%
Ranking
Category
Stock Price
$20.46
ChartMarket Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.27B, an increase of 73.30%. That is a compound annual growth rate of 6.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 3.27B | 35.13% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 3.43B |
| Legend Biotech | 3.41B |
| Viking Therapeutics | 3.38B |
| Arcus Biosciences | 3.21B |
| Dyne Therapeutics | 3.20B |
| Arcutis Biotherapeutics | 3.19B |
| uniQure | 3.05B |
| MBX Biosciences | 3.03B |